...
机译:欧洲癌症核心问卷(EORTC PATSAT-C33)和特定互补门诊模块研究和治疗欧洲研究和治疗癌症满意组织的第三阶段研究(EORTC OUT-PATSAT7)
Inst Curie Psychooncol Unit Paris France;
CHU Besancon Qual Life &
Canc Clin Res Platform Methodol &
Qual Life Oncol Unit INSERM UMR 1098;
East &
North Hertfordshire NHS Trust Including Mt Lynda Jackson Macmillan Ctr London England;
Ignatianum Acad Fac Educ Dept Gerontol Geriatr &
Social Work Hlth Outcomes Res Unit Krakow;
Complejo Hosp Navarre Dept Oncol Pamplona Spain;
Inst Integrat Med Palliat Care &
Internal Med Recife PE Brazil;
Martin Luther Univ Halle Wittenberg Inst Hlth &
Nursing Sci Halle Germany;
Basingstoke &
North Hampshire Hosp Basingstoke Hants England;
Karolinska Univ Hosp Ctr Digest Dis Karolinska Inst Dept Oncology Pathol Stockholm Sweden;
Sapienza Univ Rome Sant Andrea Hosp Psychoncol Unit Fac Med &
Psychol Rome Italy;
Bank Cyprus Oncol Ctr Nicosia Cyprus;
CHU Angers Pulmonol Dept Angers France;
Univ Lorraine CNRS Inst Cancerol Lorraine Surg Dept CRAN UMR 7039 Vandoeuvre Les Nancy France;
Jagiellonian Univ Med Coll Dept Med Educ Krakow Poland;
Natl Taiwan Univ Coll Publ Hlth Inst Prevent Med Taipei Taiwan;
Basingstoke &
North Hampshire Hosp Basingstoke Hants England;
Inst Curie Psychooncol Unit Paris France;
Lorraine Univ Inst Cancerol Lorraine Med Oncol Dept Vandoeuvre Les Nancy France;
Netherlands Canc Inst Div Psychosocial Res &
Epidemiol Amsterdam Netherlands;
EORTC Qual Life Dept Brussels Belgium;
CHU Besancon Qual Life &
Canc Clin Res Platform Methodol &
Qual Life Oncol Unit INSERM UMR 1098;
Netherlands Canc Inst Div Psychosocial Res &
Epidemiol Amsterdam Netherlands;
cancer care; EORTC PATSAT; inpatient; outpatient; patient satisfaction; questionnaire development;
机译:欧洲癌症核心问卷(EORTC PATSAT-C33)和特定互补门诊模块研究和治疗欧洲研究和治疗癌症满意组织的第三阶段研究(EORTC OUT-PATSAT7)
机译:与癌症护理核心问卷和门诊模块的EORTC满意度预测
机译:系统审查欧洲患者患者患者满意度的研究和治疗患者患者的测量特性,EORTC IN-PATSAT32
机译:欧洲癌症研究和治疗住院患者对护理满意度调查组织EORTC IN-PATSAT32的测量特性的系统评价
机译:重组粒细胞巨噬细胞集落刺激因子在61岁及以上急性髓样白血病(AML)患者缓解诱导化疗期间和之后的应用:AML-11的最终报告,这是欧洲白血病合作小组进行的一项III期随机研究癌症研究和治疗组织(EORTC-LCG)和荷兰比利时血液肿瘤合作组(HOVON)